View clinical trials related to Pediatric Emergency Medicine.
Filter by:The goal of this clinical trial is to test giving all medical/non-medical information in the pediatric emergency room(ER). Main questions it aims to answer are: - Does providing medical/non-medical information to parents of patients visiting the emergency room raise the satisfaction with the ER visit? - Does providing medical/non-medical information to parents of patients visiting the emergency room lower the workload of medical staff? 60 participants will be randomly assigned to treatment group and control group. Both groups will communicate freely with the researchers through mobile chat service. Treatment group will get information of medical/non-medical information in emergency room and control group will get information if they need. Before leaving the emergency room, both group will fill out a questionnaire related to satisfaction with the emergency room visits. 5 out of 30 participants of each group will be interviewed about their satisfaction with service. 10 nurses in charge of patients participating in the study record the number of questions directly received and 5 out of 10 nurse will be interviewed about their nursing experience for participants using mobile chatbot service. Researchers will compare treatment group and control group to see if providing medical/non-medical information raise the satisfaction with emergency room visits.
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.